1.Bae JS., Kim BJ. Subclinical diabetic neuropathy with normal con-ventional electrophysiological study. J Neurol. 2007. 254:53–59.
Article
2.Kuwabara S., Misawa S. Axonal ionic pathophysiology in human peripheral neuropathy and motor neuron disease. Curr Neuro-vasc Res. 2004. 1:373–379.
Article
3.Nodera H., Kaji R. Nerve excitability testing and its clinical application to neuromuscular diseases. Clin Neurophysiol. 2006. 117:1902–1916.
Article
4.Kiernan MC., Burke D., Andersen KV., Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve. 2000. 23:399–409.
Article
5.Burke D., Kiernan MC., Bostock H. Excitability of human axons. Clin Neurophysiol. 2001. 112:1575–1585.
Article
6.Jankelowitz SK., McNulty PA., Burke D. Changes in measures of motor axon excitability with age. Clin Neurophysiol. 2007. 118:1397–1404.
Article
7.Bae JS., Sawai S., Misawa S., Kanai K., Isose S., Shibuya K, et al. Effects of age on excitability properties in human motor axons. Clin Neurophysiol. 2008. 119:2282–2286.
Article
8.Paeing SH., Kang MR., Ahn SH., Lee MW., Pyun SY., Bostock H, et al. Relative sparing of the second lumbrical muscle in carpal tunnel syndrome is not associated with regional differences in axonal membrane potential. Clin Neurophysiol. 2016. 127:905–910.
Article
9.Bae JS., Kim OK., Kim JM. Altered nerve excitability in subclinical/early diabetic neuropathy: evidence for early neurovascular pro-cess in diabetes mellitus? Diabetes Res Clin Pract. 2011. 91:183–189.
Article
10.Mogyoros I., Kiernan MC., Burke D. Strength-duration properties of human peripheral nerve. Brain. 1996. 119(Pt 2):439–447.
Article
11.Z'Graggen WJ., Lin CS., Howard RS., Beale RJ., Bostock H. Nerve excitability changes in critical illness polyneuropathy. Brain. 2006. 129(Pt 9):2461–2470.
12.Murray JE., Jankelowitz SK. A comparison of the excitability of motor axons innervating the APB and ADM muscles. Clin Neurophysiol. 2011. 122:2290–2293.
Article
13.Jankelowitz SK., Burke D. Axonal excitability in the forearm: normal data and differences along the median nerve. Clin Neurophysiol. 2009. 120:167–173.
Article
14.Kiernan MC., Cikurel K., Bostock H. Effects of temperature on the excitability properties of human motor axons. Brain. 2001. 124(Pt 4):816–825.
Article
15.Mogyoros I., Kiernan MC., Burke D., Bostock H. Excitability changes in human sensory and motor axons during hyperventilation and ischaemia. Brain. 1997. 120(Pt 2):317–325.
Article
16.Krishnan AV., Phoon RK., Pussell BA., Charlesworth JA., Bostock H., Kiernan MC. Altered motor nerve excitability in end-stage kidney disease. Brain. 2005. 128(Pt 9):2164–2174.
Article
17.Bostock H., Cikurel K., Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve. 1998. 21:137–158.
Article
18.Kiernan MC., Lin CS., Andersen KV., Murray NM., Bostock H. Clinical evaluation of excitability measures in sensory nerve. Muscle Nerve. 2001. 24:883–892.
Article
19.Kuwabara S. Physiological differences in excitability among human axons. Clin Neurophysiol. 2009. 120:1–2.
Article
20.Lin CS., Mogyoros I., Kuwabara S., Cappelen-Smith C., Burke D. Accommodation to depolarizing and hyperpolarizing currents in cutaneous afferents of the human median and sural nerves. J Physiol. 2000. 529(Pt 2):483–492.
Article
21.Bae JS. Automated nerve excitability test by utilizing threshold tracking technique. Korean J Clin Neurophysiol. 2014. 16(Suppl 1):82–86.
22.Krishnan AV., Lin CS., Kiernan MC. Nerve excitability properties in lower-limb motor axons: evidence for a length-dependent gra-dient. Muscle Nerve. 2004. 29:645–655.
Article